Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-16 Sale | 2024-04-18 5:12 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $7.6636 | $87,725 | 7,229,861 (Direct) | View |
| 2024-04-02 Sale | 2024-04-03 5:42 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $8.8182 | $100,942 | 7,241,308 (Direct) | View |
| 2024-03-19 Sale | 2024-03-21 5:38 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 20,054 | $10.79 | $216,423 | 7,252,755 (Direct) | View |
| 2024-03-05 Sale | 2024-03-07 6:53 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 20,054 | $12.06 | $241,805 | 7,272,809 (Direct) | View |
| 2024-02-20 Sale | 2024-02-21 5:37 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 20,054 | $12.32 | $247,125 | 7,292,863 (Direct) | View |
| 2024-02-06 Sale | 2024-02-08 6:54 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $9.3028 | $106,489 | 7,312,917 (Direct) | View |
| 2024-01-23 Sale | 2024-01-25 6:13 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 20,054 | $10.58 | $212,083 | 7,324,364 (Direct) | View |
| 2024-01-09 Sale | 2024-01-11 6:50 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 20,054 | $13.62 | $273,202 | 7,344,418 (Direct) | View |
| 2023-12-26 Sale | 2023-12-28 5:48 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 20,054 | $10.63 | $213,144 | 7,364,472 (Direct) | View |
| 2023-12-12 Sale | 2023-12-14 6:51 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $7.3987 | $84,693 | 7,384,526 (Direct) | View |
| 2023-11-28 Sale | 2023-11-30 5:41 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 11,447 | $6.7195 | $76,918 | 7,395,973 (Direct) | View |
| 2023-11-14 Sale | 2023-11-16 6:55 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $6.3197 | $56,151 | 7,407,420 (Direct) | View |
| 2023-10-31 Sale | 2023-11-02 7:02 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $5.2745 | $46,864 | 7,416,305 (Direct) | View |
| 2023-10-17 Sale | 2023-10-19 5:34 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $6.5822 | $58,483 | 7,425,190 (Direct) | View |
| 2023-10-03 Sale | 2023-10-05 6:25 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $7.2907 | $64,778 | 7,434,075 (Direct) | View |
| 2023-09-19 Sale | 2023-09-21 6:35 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $8.3599 | $74,278 | 7,442,960 (Direct) | View |
| 2023-09-05 Sale | 2023-09-07 7:02 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $8.7942 | $78,136 | 7,451,845 (Direct) | View |
| 2023-08-22 Sale | 2023-08-24 5:51 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $8.9118 | $79,181 | 7,460,730 (Direct) | View |
| 2023-08-08 Sale | 2023-08-10 5:33 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 17,770 | $11.16 | $198,283 | 7,469,615 (Direct) | View |
| 2023-07-25 Sale | 2023-07-27 6:30 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 18,719 | $14.61 | $273,464 | 7,487,385 (Direct) | View |
| 2023-07-11 Sale | 2023-07-13 4:54 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $6.8873 | $61,194 | 7,520,104 (Direct) | View |
| 2023-06-27 Sale | 2023-06-29 5:57 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $7.3876 | $65,639 | 7,528,989 (Direct) | View |
| 2023-06-13 Sale | 2023-06-15 7:30 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 15,485 | $9.9778 | $154,506 | 7,525,262 (Direct) | View |
| 2023-05-30 Sale | 2023-06-01 5:41 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $8.7939 | $78,134 | 7,540,747 (Direct) | View |
| 2023-05-16 Sale | 2023-05-17 6:22 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $5.0918 | $45,241 | 7,549,632 (Direct) | View |
| 2023-04-18 Sale | 2023-04-20 5:37 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $5.9347 | $52,730 | 7,558,517 (Direct) | View |
| 2023-04-04 Sale | 2023-04-06 5:38 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $6.5269 | $57,992 | 7,567,402 (Direct) | View |
| 2023-03-21 Sale | 2023-03-23 5:07 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $7.3994 | $65,744 | 7,576,287 (Direct) | View |
| 2023-03-07 Sale | 2023-03-09 5:36 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $8.3274 | $73,989 | 7,585,172 (Direct) | View |
| 2023-02-21 Sale | 2023-02-23 5:48 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $7.733 | $68,708 | 7,594,057 (Direct) | View |
| 2023-02-07 Sale | 2023-02-09 4:53 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $8.8084 | $78,263 | 7,602,942 (Direct) | View |
| 2023-01-24 Sale | 2023-01-26 6:04 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $8.7077 | $77,368 | 7,611,827 (Direct) | View |
| 2023-01-10 Sale | 2023-01-12 5:46 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $7.6852 | $68,283 | 7,620,712 (Direct) | View |
| 2022-12-27 Sale | 2022-12-29 5:39 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $7.2451 | $64,373 | 7,628,272 (Direct) | View |
| 2022-12-13 Sale | 2022-12-15 5:26 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $8.9587 | $79,598 | 7,637,157 (Direct) | View |
| 2022-11-29 Sale | 2022-12-01 5:14 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 8,885 | $8.7547 | $77,786 | 7,646,042 (Direct) | View |
| 2022-11-16 Sale | 2022-11-18 5:47 pm | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 17,770 | $11.12 | $197,610 | 7,654,927 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-06-29 Gift | 2023-07-27 6:30 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 14,000 | $0 | 7,487,385 (Direct) | View |
| 2023-06-16 Option Award | 2023-06-21 5:24 pm | 2024-06-16 2033-06-16 | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 37,836 | $0 | 7,611,888 (Direct) | View |
| 2023-01-03 Option Award | 2023-01-05 6:28 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 1,325 | $0 | 7,629,597 (Direct) | View |
| 2022-10-03 Option Award | 2022-10-05 9:10 pm | N/A N/A | RECURSION PHARMACEUTICALS INC. | RXRX | Borgeson Blake Director | 920 | $0 | 7,672,697 (Direct) | View |